Velan Capital Investment Management LP

CIK 0001848809 · ALPHARETTA, GA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source

Velan Capital Investment Management LP reported 51 positions worth $164.2M as of June 30, 2026 (13F filed August 14, 2026). Largest holding: PRAX (18.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$164.2M
2026 Q2
Positions
51
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
74.8%
Est. Net Flow (Q)
2026 Q2
10 / 51 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1PRAXPRAXIS PRECISION MEDICINES ISH$29.7M18.10%88,781
2MPLTMAPLIGHT THERAPEUTICS INCSH$17.7M10.76%492,893
3STROSUTRO BIOPHARMA INCSH$17.0M10.36%512,160
4IMMXIMMIX BIOPHARMA INCSH$11.2M6.81%1,085,000
5TARAPROTARA THERAPEUTICS INCSH$10.9M6.62%2,844,652
6ABVXABIVAX SASH$8.7M5.33%65,630
7TENXTENAX THERAPEUTICS INCSH$8.0M4.87%549,985
8AVRANTERIS TECHNOLOGIES GLOBALSH$6.9M4.20%700,000
9EDSAEDESA BIOTECH INCSH$6.7M4.10%827,500
10EVMNEVOMMUNE INCSH$6.0M3.65%451,255

The free plan shows the top 10 positions. The remaining 41 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Velan Capital Investment Management LP hold as of Q2 2026?

Velan Capital Investment Management LP reported 51 positions worth $164.2M in its Q2 2026 13F filing. Largest positions: PRAX (18.1%), MPLT (10.8%), STRO (10.4%), IMMX (6.8%) and TARA (6.6%).

What did Velan Capital Investment Management LP buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Velan Capital Investment Management LP sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.